nicorandil has been researched along with Intestinal Perforation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SS; Chen, YS; Gabriel Lee, MT; Hsu, WT; Lee, CC; Lee, SH | 1 |
| Lyon, CC; Smith, VM | 1 |
| Jansen, JO; King, PM; Suttie, SA; Watson, AJ | 1 |
3 other study(ies) available for nicorandil and Intestinal Perforation
| Article | Year |
|---|---|
Use of nicorandil is Associated with Increased Risk for Gastrointestinal Ulceration and Perforation- A Nationally Representative Population-based study.
Topics: Adult; Aged; Humans; Intestinal Perforation; Nicorandil; Risk Assessment; Risk Factors; Stomach Ulcer; Taiwan; Time Factors; Treatment Outcome | 2015 |
Nicorandil: do the dermatological and gastrointestinal risks outweigh the benefits?
Topics: Aged; Aged, 80 and over; Angina Pectoris; Female; Gastrointestinal Diseases; Humans; Intestinal Fistula; Intestinal Perforation; Male; Middle Aged; Nicorandil; Risk Assessment; Skin Ulcer; Vasodilator Agents | 2012 |
Perforation of the terminal ileum: a possible complication of nicorandil therapy.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ileal Diseases; Intestinal Perforation; Laparotomy; Middle Aged; Myocardial Ischemia; Nicorandil; Risk Assessment; Treatment Outcome; Ulcer | 2004 |